cancer doctors

Pancreas Cancer Survival

Question: What is the current treatment and prognosis for the average survival rate of pancreas cancer? THIS NEEDS TO BE CANADIAN INFO

Answer: Generally speaking, there are only two treatments for pancreatic cancer, depending on both the stage as well as the location on the pancreas. The surgical treatment, coupled with post-surgical chemo-therapy, can be subdivided into two types: A. The Whipple Procedure: When pancreatic cancer involving the head of the pancreas is diagnosed, the removal of the head of the pancreas as well as the curve of the duodenum (Pancreato-Duodenectomy) is performed, whereas bypassing the stomach to the jejunum of the intestine is necessary. This procedure can only be performed if the cancer is localized to the head of the pancreas only, and has not metastasized to adjacent parts or organs. B. Distal Pancreatectomy is performed when cancer involves the body and the distal part of the pancreas, in which they are removed. In this case, the spleen is mostly preserved. In both cases, the procedure can be very vastly invasive, and as such, not only does the patient need to meet the diagnostic criteria of being diagnosed at a sufficiently early stage, without any metastasis, but that the patient should be in a condition that is good enough to undergo majorly ivnasive surgery of this caliber. However, there have been attempts at performing such procedures laparoscopically, being minimally invasive. However, many oncologists generally prefer performing the procedure the "usual" way, as they get a better look of things and get to be more aggressive in terms of removal of affected organs as they need to be. Needless to say, not many patients meet those criteria, simply due to the fact that pancreatic cancer is often diagnosed at more advanced stages, and considering the fact that patients aren't always in the physical condition to withstand surgery. The alternative treatment is chemotherapy using gemcitabine, for patients who are not fit for surgery, is used. It does not cure the cancer, but it improves the 5-year survival rate by 20% at best, sadly. However, it does improve the quality of life for patients. The average survival rate from diagnosis on is generally 3-6 months in metastasized/advaced stage cancer, in which cases they are deemed terminal. However, if it is diagnozed sufficiently early, the prognosis can be very good-- with surgery and chemotherapy, the patient -can- actually have a full recovery, except for becoming diabetic. But again, sadly, pancreatic cancer patients are often diagnosed at advanced stages due to the aggressive nature of the malignancy as well as the type of symptoms it presents with, which generally leads patients to dismiss it until it has metastasized and is causing more serious symptoms.


Pancreas Cancer Survival News

Lessons from Cancer: Love is divine

Maryville Daily Forum
So I'm going for a miracle and at the very least, stability and control of the lung cancer with good quality of life as I learn to live with it as a chronic disease while I still pray that the pancreas cancer doesn't come back.
 

Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co ...

MarketWatch (press release)
TH-302 is currently being investigated in a global Phase 3 clinical trial in patients with soft tissue sarcoma, a randomized Phase 2 trial in patients with advanced pancreatic cancer from which top-line results are expected in February, ...
 

UA News (press release)

UA Awarded National Cancer Research Grant
UA News (press release)
 

HealthNews

Diabetes drugs tied to pancreatic cancer risk
HealthNews
 

Hindustan Times

Coming back stronger
Hindustan Times
 

The Guardian

Nanotechnology and the fight against cancer
The Guardian
 

New target for cancer therapy identified, preclinical study shows

Medical Xpress
Tumors often develop survival mechanisms to prevent the attack from the immune system. Researchers are now looking to evaluate the mechanisms that enable these tumors to escape detection by the immune system. Previously, Brussels scientists from LICR ...
 

Grant of $600000 will be used for local pancreatic cancer research

Arizona Daily Star (blog)
One specific area of research focuses on the development of agents that target the mutated K-Ras gene, which signals cancer cells to proliferate, migrate and survive. Mutations in the K-Ras gene are found in more than 95 percent of pancreatic cancers.
 

Immunotherapy Cancer Trials With Key Data Due In 2012

Seeking Alpha
Its overexpression is implicated in many cancers of the lungs, breast, colon, ovaries and pancreas. Cancer vaccines must have a target or a means by which to differentiate cancer cells from normal healthy cells in order to have the desired specificity.
 

Genetic Mutation That Triggers Pancreatic Cancer Identified

Medical News Today
This process produces a pro-tumor microenvironment by promoting generation of new blood vessels, inflammation, and tissue repair comparable to conditions found in inherited pancreatitis, inflammation of the pancreas that is associated to the ...
 

Types of Cancer


Adrenal Cancer Anal Cancer Brain Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer
Esophageal Cancer Laryngeal Cancer Oral Cancer Penile Cancer Prostatic Cancer Stomach Cancer
Thyroid Cancer Bladder Cancer Bone Cancer Cervix Cancer Heart Cancer Kidney Cancer
Melanoma Cancer Pancreas Cancer Asbestos Cancer